Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment-Reference-Cited by-同舟云学术

Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment

Published:2023-08 Issue: Volume:360 Page:940-952
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Choi Sun Il,Lee Yu-Sun,Lee Yul Min,Kim Hyun Jung,Kim Won Jong,Jung Sungjin,Im Ji Eun,Lee Mi Rim,Kim Joon Ki,Jeon A-Ra,Woo Sang Myung,Oh Goo Taeg,Heo Kyun,Kim Yun-Hee,Kim In-Hoo

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2022

2. Burden of pancreatic cancer: from epidemiology to practice;Khalaf;Clin. Gastroenterol. Hepatol.,2021

3. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Ducreux;Ann. Oncol.,2015

4. A basic insight into aptamer-drug conjugates (ApDCs);Xuan;Biomaterials,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions;Pharmacological Research;2024-09

2. Breaking Barriers: Nucleic Acid Aptamers in Gastrointestinal (GI) Cancers Therapy;Cell Biochemistry and Biophysics;2024-06-25

3. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy;International Journal of Pharmaceutics;2024-06

4. Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer;Journal of Controlled Release;2024-01

5. CAR‐Aptamers Enable Traceless Enrichment and Monitoring of CAR‐Positive Cells and Overcome Tumor Immune Escape;Advanced Science;2023-12-26